Midodrine Hydrochloride
NDC 82293-005, Midodrine Hydrochloride, tablet, from Novugen Pharma (USA) LLC.
- Product NDC
- 82293-005
- Status
- Listed
- Labeler
- Novugen Pharma (USA) LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA211973
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/82293-005 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MIDODRINE HYDROCHLORIDE10 mg/1
Pharmacologic classes
Adrenergic alpha-Agonists [MoA]; alpha-Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 82293-005-10 | 82293000510 | 100 TABLET in 1 BOTTLE (82293-005-10) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/2bf011fe-d114-42a4-93e2-76a993a3ba34NADAC price for package 82293000510
GET /v1/drugs/nadac/82293000510
Use it
Look up 82293-005 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/82293-005 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 82293-005. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.